Askorel Syrup

Brand Name: Askorel
Generic: Butamirate Citrate
Weight: 7.5 mg/5 ml
Type: Syrup
Therapeutic Class: Cough suppressant
Manufacturer: Incepta Pharmaceuticals Limited
Price: 112.00
Last Updated: 2020-11-21 18:15:00

Askorel Syrup Uses

Askorel Syrup contains Butamirate Citrate. Askorel uses:

Butamirate Citrate is indicated in acute cough of any etiology, suppression of pre-& post-operative cough in surgery & bronchoscopy and suppression of whooping cough.

Askorel Syrup Doses

Askorel Syrup contains Butamirate Citrate 7.5 mg/5 ml. Askorel doses:


  • Adult: 2-3 tablets daily at 8 to 12 hours intervals,
  • Adolescents over 12 years old: 1-2 tablets daily.


  • Children (3-6 years): 5 ml 3 times daily,
  • Children (6-12 years): 10 ml 3 times daily,
  • Adolescent: 15 ml 3 times daily,
  • Adult: 15 ml 4 times daily.

Pediatric Drops:

  • Children (1-3 years): 0.75 ml 4 times daily,
  • Children (2 months-1 year): 0.50 ml 4 times daily.


Side Effects

Tolerance of Butamirate Citrate is good. Adverse reactions such as rash, nausea, diarrhea and vertigo have been observed in a few rare cases, resolving after dose reduction or treatment withdrawal.


Butamirate Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, moderate bronchodilating and anti-inflammatory action. Butamirate Citrate also increases the spirometery indexes and blood oxygenation. It is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. The active metabolites of Butamirate Citrate have also antitussive action.

Askorel Precaution

Avoid simultanous administration of expectorants. Minor influence on the ability to drive & use machines. Avoid during pregnancy (1st 3 months) & lactation.

Tablet: Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. 

Syrup: Sorbitol: Rare hereditary problems of fructose intolerance. Contains ethanol.


Avoid use with expectorants.

Pregnancy Lactation use

Butamirate Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Butamirate Citrate administration during breast feeding should be carefully weighed against the risks.


Butamirate Citrate is contraindicated in patients with known hypersensitivity to any component of the formulation.

Special Warning


Acute Overdose

Accidental overdose with Butamirate Citrate can cause the following symptoms: drowsiness, nausea, vomiting, diarrhea, loss of balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.

Interaction with other Medicine


Storage Condition

Do not store above 30 0 C. Keep away from light and out of the reach of children.

Askorel Syrup price in Bangladesh 112.00